DIN ISO 13022:2014-06
Current
Current
The latest, up-to-date edition.
MEDICAL PRODUCTS CONTAINING VIABLE HUMAN CELLS - APPLICATION OF RISK MANAGEMENT AND REQUIREMENTS FOR PROCESSING PRACTICES (ISO 13022:2012)
Available format(s)
Hardcopy , PDF
Language(s)
German
Published date
01-01-2014
This standard is included in DIN Handbook 406.
DocumentType |
Standard
|
Pages |
54
|
PublisherName |
German Institute for Standardisation (Deutsches Institut für Normung)
|
Status |
Current
|
Standards | Relationship |
ISO 13022:2012 | Identical |
ISO 13408-4:2005 | Aseptic processing of health care products — Part 4: Clean-in-place technologies |
ISO/TR 22442-4:2010 | Medical devices utilizing animal tissues and their derivatives Part 4: Principles for elimination and/or inactivation of transmissible spongiform encephalopathy (TSE) agents and validation assays for those processes |
ASTM F 2386 : 2004 | Standard Guide for Preservation of Tissue Engineered Medical Products (TEMPs) (Withdrawn 2013) |
ISO 7010:2011 | Graphical symbols Safety colours and safety signs Registered safety signs |
ISO 13408-7:2012 | Aseptic processing of health care products — Part 7: Alternative processes for medical devices and combination products |
ASTM F 2312 : 2011 : REDLINE | Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 2149 : 2016 : REDLINE | Standard Test Method for Automated Analyses of Cells—the Electrical Sensing Zone Method of Enumerating and Sizing Single Cell Suspensions |
DIN EN ISO 13485:2016-08 | Medical devices - Quality management systems - Requirements for regulatory purposes (ISO 13485:2016) |
ISO 13408-2:2003 | Aseptic processing of health care products Part 2: Filtration |
ISO 13485:2016 | Medical devices Quality management systems Requirements for regulatory purposes |
CFR 21(PTS800-1299) : 0 | FOOD AND DRUGS - FOOD AND DRUG ADMINISTRATION, CHAPTER 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES - PARTS 800-1299 |
ASTM F 2385 : 2015 : REDLINE | Standard Practice for Determining Femoral Head Penetration into Acetabular Components of Total Hip Replacement Using Clinical Radiographs |
DIN EN ISO 14971:2013-04 | MEDICAL DEVICES - APPLICATION OF RISK MANAGEMENT TO MEDICAL DEVICES (ISO 14971:2007) |
ISO 22442-1:2015 | Medical devices utilizing animal tissues and their derivatives Part 1: Application of risk management |
ASTM F 2383 : 2011 : REDLINE | Standard Guide for Assessment of Adventitious Agents in Tissue Engineered Medical Products (TEMPs) |
ASTM F 2027 : 2016 : REDLINE | Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products |
ISO 13408-3:2006 | Aseptic processing of health care products Part 3: Lyophilization |
ISO/IEC Guide 51:2014 | Safety aspects — Guidelines for their inclusion in standards |
EN 166:2001 | Personal eye-protection - Specifications |
ISO 13408-1:2008 | Aseptic processing of health care products — Part 1: General requirements |
DIN EN ISO 22442-2:2016-05 | Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and handling (ISO 22442-2:2015) |
ASTM F 2739 : 2016 | Standard Guide for Quantifying Cell Viability within Biomaterial Scaffolds |
DIN EN ISO 14155:2012-01 | CLINICAL INVESTIGATION OF MEDICAL DEVICES FOR HUMAN SUBJECTS - GOOD CLINICAL PRACTICE (ISO 14155:2011 + COR. 1:2011) |
ISO 22442-2:2015 | Medical devices utilizing animal tissues and their derivatives Part 2: Controls on sourcing, collection and handling |
EN 511:2006 | Protective gloves against cold |
ASTM F 2211 : 2013 | Standard Classification for Tissue Engineered Medical Products (TEMPs) |
DIN EN ISO 22442-3:2008-03 | MEDICAL DEVICES UTILIZING ANIMAL TISSUES AND THEIR DERIVATIVES - PART 3: VALIDATION OF THE ELIMINATION AND/OR INACTIVATION OF VIRUSES AND TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY (TSE) AGENTS |
ISO 14155:2011 | Clinical investigation of medical devices for human subjects Good clinical practice |
ISO 22442-3:2007 | Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents |
ISO 14971:2007 | Medical devices Application of risk management to medical devices |
DIN EN ISO 7010:2012-10 | GRAPHISCHE SYMBOLE - SICHERHEITSFARBEN UND SICHERHEITSZEICHEN - REGISTRIERTE SICHERHEITSZEICHEN (ISO 7010:2011/AMD 5:2014) |
EN 1251-3:2000 | Cryogenic vessels - Transportable vacuum insulated vessels of not more than 1000 litres volume - Part 3: Operational requirements |
ISO 13408-6:2005 | Aseptic processing of health care products Part 6: Isolator systems |
ISO 13408-5:2006 | Aseptic processing of health care products Part 5: Sterilization in place |
DIN EN ISO 22442-1:2016-05 | Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management (ISO 22442-1:2015) |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.